The Prevalence, Genotype and Antimicrobial Susceptibility of High- and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Background: Mupirocin has been used for the treatment of skin infections and eradication of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA). The increased use of this antibiotic has been accompanied by outbreaks of MRSA that are resistant to mupirocin. Objective: This study aims to determine the prevalence, genotype and antimicrobial susceptibility of mupirocin-resistant MRSA from 4 Korean hospitals. Methods: A total 193 MRSA clinical isolates were collected from four university hospitals. Antimicrobial susceptibility tests, including mupirocin, and pulsed-field gel electrophoresis (PFGE) pattern analysis were performed. Results: Overall, 27 of the 193 (14.1%) MRSA isolates were resistant to mupirocin. All of the (A) hospital isolates showed high-level (HL) mupirocin resistance and the low-level (LL)mupirocin resistant strains were from three other hospitals. The PFGE patterns of 16 mupirocin-resistant isolates were divided into 5 clusters (1-5), and the nine HL mupirocinresistant isolates belonged to cluster 1. Both the HL and LL mupirocin-resistant MRSA isolates were susceptible to vancomycin and rifampin, but they were resistant to ciprofloxacin,clindamycin and tetracycline. The erythromycin and fusidic acid resistance rates were different between the HL and LL resistant isolates. Conclusion: HL mupirocin-resistant isolates that could transfer this resistance to other bacteria were detected and these isolates were clonally related. The emergence of mupirocin resistant isolates emphasizes the importance of using antibiotics judiciously and carefully monitoring the prevalence of mupirocin resistance.
Abstract
Background: Mupirocin has been used for the treatment of skin infections and eradication of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA). The increased use of this antibiotic has been accompanied by outbreaks of MRSA that are resistant to mupirocin. Objective: This study aims to determine the prevalence, genotype and antimicrobial susceptibility of mupirocin-resistant MRSA from 4 Korean hospitals. Methods: A total 193 MRSA clinical isolates were collected from four university hospitals. Antimicrobial susceptibility tests, including mupirocin, and pulsed-field gel electrophoresis (PFGE) pattern analysis were performed. Results: Overall, 27 of the 193 (14.1%) MRSA isolates were resistant to mupirocin. All of the (A) hospital isolates showed high-level (HL) mupirocin resistance and the low-level (LL)mupirocin resistant strains were from three other hospitals. The PFGE patterns of 16 mupirocin-resistant isolates were divided into 5 clusters (1-5), and the nine HL mupirocinresistant isolates belonged to cluster 1. Both the HL and LL mupirocin-resistant MRSA isolates were susceptible to vancomycin and rifampin, but they were resistant to ciprofloxacin,clindamycin and tetracycline. The erythromycin and fusidic acid resistance rates were different between the HL and LL resistant isolates. Conclusion: HL mupirocin-resistant isolates that could transfer this resistance to other bacteria were detected and these isolates were clonally related. The emergence of mupirocin resistant isolates emphasizes the importance of using antibiotics judiciously and carefully monitoring the prevalence of mupirocin resistance.
참고문헌 (26)
- Sutherland R, "Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use", Antimicrob Agents Chemother, 27, pp.495~498 (1985)
- Simor AE, "Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals", Antimicrob Agents Chemother, 51, pp.3880~3886 (2007)
- Cookson BD, "The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice", J Antimicrob Chemother, 41, pp.11~18 (1998)
- Yun HJ, "Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital", J Antimicrob Chemother, 51, pp.619~623 (2003)
- Yoo JI, "Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea", Antimicrob Agents Chemother, 50, pp.365~367 (2006)
- Jin Ah Yang, "Molecular Analysis of Isoleucyl-tRNA Synthetase Mutations in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus with Low-Level Mupirocin Resistance", Journal of Korean Medical Science, 21(5), pp.827~832 (2006), 대한의학회
- Clinical and Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition" (2009), Clinical and Laboratory Standards Institute
- Lee HK, "Relationship between the level of methicillin resistance and mecA, mecI, femA genes genes in Staphylococci", Korean J Infect Dis, 30, pp.36~44 (1998)
- Yokoyama T, "Study on mec gene in methicillin-resistant staphylococci", Kansenshogaku Zasshi, 67, pp.1203~1210 (1993)
- Ramsey MA, "Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates", Antimicrob Agents Chemother, 40, pp.2820~2823 (1996)
- Murchan S, "Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains", J Clin Microbiol, 41, pp.1574~1585 (2003)
- Heyndrickx M, "A polyphasic reassessment of the genus Paenibacillus, reclassification of Bacillus lautus (Nakamura 1984) as Paenibacillus lautus comb. nov. and of Bacillus peoriae (Montefusco et al. 1993) as Paenibacillus peoriae comb. nov., and emended descriptions of P. lautus and of P. peoriae", Int J Syst Bacteriol, 46, pp.988~1003 (1996)
- Sokal RR, "A statistical method for evaluating systematic relationships", University of Kansas Scientific Bulletin, 28, pp.1409~1438 (1958)
- Rahman M, "Mupirocinresistant staphylococcus aureus", Lancet, 330, pp.387~388 (1987)
- Conly JM, "Increasing mupirocin resistance of Staphylococcus aureus in CAPD--should it continue to be used as prophylaxis?", Perit Dial Int, 22, pp.649~652 (2002)
- Pérez-Fontán M, "Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis", Am J Kidney Dis, 39, pp.337~341 (2002)
- Wise R, "Mupirocin resistance", Lancet, 338(8766), pp.578~ (1991)
- Lee HJ, "Typing and antimicrobial susceptibilities of methicillin resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea", J Korean Med Sci, 16, pp.381~385 (2001)
- Redhead RJ, "The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage", Br J Clin Pract, 45, pp.252~254 (1991)
- Janssen DA, "Detection and characterization of mupirocin resistance in Staphylococcus aureus", Antimicrob Agents Chemother, 37, pp.2003~2006 (1993)
- Chaves F, "Molecular characterization of resistance to mupirocin in methicillinsusceptible and -resistant isolates of Staphylococcus aureus from nasal samples", J Clin Microbiol, 42, pp.822~824 (2004)
- Thomas DG, "Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro", J Appl Microbiol, 86, pp.715~722 (1999)
- Bastos MC, "Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin", Eur J Clin Microbiol Infect Dis, 18, pp.393~398 (1999)
- Shin-Moo Kim, "Genotype, Coagulase Type and Antimicrobial Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolated from Dermatology Patients and Healthy Individuals in Korea", Journal of Bacteriology and Virology, 39(4), pp.307~316 (2009), 대한미생물학회
- Maple PA, "Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus", J Antimicrob Chemother, 29, pp.661~668 (1992)
- Riley TV, "Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia", Med J Aust, 161, pp.397~398 (1994)